Drawing for INNOPSYS

USPTO serial 79330988

INNOPSYS

Reviewed by CopyMark Law Group

Reg. 7045392Status 700Registered
Filing date
Status date
Registration date
May 9, 2023
Examiner
OSGOOD, KRYSTINA E
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with INNOPSYS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Nicholas D. Wells

Nicholas D. Wells Legends Law Group, PLLC330 Main St.Kaysville, UT 84037UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
009Electronic optical signal acquisition instruments, namely, optical transmitters, fluorescence acquisition scanners and optical scanners; optoelectronic instruments, namely, electronic and optical light sensors for image analysis, for scientific, laboratory or industrial use in the field of biotechnology, and not for medical purposesACTIVE—
010Medical and surgical apparatus and instruments, namely cell and tissue fluorescence scanner, microarray scanners, optical sensors for low light detection all for use in medical diagnosis and treatment, neurological stimulators, namely, electronic nerve stimulators for medical purposes, nerve stimulation probes, optometric instruments, namely, medical imaging apparatus in the nature of high-density scanners; apparatus and instruments for medical diagnosis, namely fluorescence imaging apparatus, medical imaging apparatus in the nature of high-density scanners; scanners for medical diagnosis, namely fluorescence scanners; biochip scanners for DNA, RNA, protein, disease and genetic testing all for medical diagnosis purposes; imaging apparatus for medical purposes; fluorescence imaging apparatus for medical purposes; medical monitoring, examination and diagnosis equipment, namely, electromagnetic medical diagnostic imaging apparatus, medical imaging apparatus for analyzing substances for diagnostic use, namely digital microscopes for surgical operations with automated high resolution imaging used for diagnosis, medical device for preoperative neurophysiological monitoring of nerves and muscles; electronic muscle and nerve stimulators for medical use; electronic nerve neurostimulators for medical use; nerve stimulator apparatus for nerve location and stimulation; stimulation probes for medical use; medical devices for neurophysiological stimulation and monitoring, namely medical devices for stimulation and monitoring of nerves and muscles of the central and peripheral nervous systemACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Sep 4, 2023FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Aug 14, 2023FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 14, 2023FIMPFINAL DISPOSITION PROCESSED—
Aug 9, 2023FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 9, 2023R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
May 9, 2023NRCCNOTICE OF REGISTRATION CONFIRMATION EMAILED—
Feb 21, 2023GPNXNOTIFICATION PROCESSED BY IB—
Feb 21, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Feb 21, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 1, 2023OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Feb 1, 2023OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Feb 1, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Jan 13, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 13, 2023XAECEXAMINER'S AMENDMENT ENTERED—
Jan 13, 2023GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Jan 13, 2023GNEAEXAMINERS AMENDMENT E-MAILED—
Jan 13, 2023CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 21, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Oct 21, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Oct 21, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
May 16, 2022RFNTREFUSAL PROCESSED BY IB—
Apr 22, 2022RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Apr 22, 2022RFRRREFUSAL PROCESSED BY MPU—
Mar 15, 2022RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Mar 14, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Mar 10, 2022DOCKASSIGNED TO EXAMINER—
Jan 18, 2022MAFRAPPLICATION FILING RECEIPT MAILED—
Jan 14, 2022NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jan 13, 2022REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance